标题
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
作者
关键词
-
出版物
Cell Death & Disease
Volume 9, Issue 2, Pages -
出版商
Springer Nature
发表日期
2018-01-25
DOI
10.1038/s41419-017-0061-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
- (2017) Lin Tian et al. NATURE
- Tumor-Associated Lymphatic Vessels Upregulate PDL1 to Inhibit T-Cell Activation
- (2017) Lothar C. Dieterich et al. Frontiers in Immunology
- Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma
- (2017) Abhishek D. Garg et al. OncoImmunology
- Anoxia and glucose supplementation preserve neutrophil viability and function
- (2016) Valérie Monceaux et al. BLOOD
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment
- (2016) Jin-Sung Park et al. CANCER CELL
- Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy
- (2016) Anna Rita Cantelmo et al. CANCER CELL
- In SituTumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments
- (2016) Zachary S. Morris et al. CANCER RESEARCH
- Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation
- (2016) A D Garg et al. CELL DEATH AND DIFFERENTIATION
- Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma
- (2016) Sarah A. Weiss et al. HUMAN PATHOLOGY
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- Lymphatic vessels regulate immune microenvironments in human and murine melanoma
- (2016) Amanda W. Lund et al. JOURNAL OF CLINICAL INVESTIGATION
- Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment
- (2016) Hanna Starobinets et al. JOURNAL OF CLINICAL INVESTIGATION
- Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
- (2016) S Chouaib et al. ONCOGENE
- Immune checkpoint inhibitors: the new frontier in non–small cell lung cancer treatment
- (2016) Hazem El-Osta et al. OncoTargets and Therapy
- Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer
- (2015) Guangmei Mao et al. ANGIOGENESIS
- Targeting the tumor vasculature to enhance T cell activity
- (2015) Evripidis Lanitis et al. CURRENT OPINION IN IMMUNOLOGY
- Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies
- (2015) Hannelore Maes et al. FEBS Journal
- Effects of extracellular pH and hypoxia on the function and development of antigen-specific cytotoxic T lymphocytes
- (2015) Yohko Nakagawa et al. IMMUNOLOGY LETTERS
- The Pleiotropic Effects of miRNAs on Tumor Angiogenesis
- (2015) Runting Yin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Vascular-targeted TNFα improves tumor blood vessel function and enhances antitumor immunity and chemotherapy in colorectal cancer
- (2015) Lan Lu et al. JOURNAL OF CONTROLLED RELEASE
- VEGF-A modulates expression of inhibitory checkpoints on CD8+T cells in tumors
- (2015) Thibault Voron et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Combination of radiotherapy with the immunocytokine L19-IL2: Additive effect in a NK cell dependent tumour model
- (2015) Nicolle H. Rekers et al. RADIOTHERAPY AND ONCOLOGY
- Immunological mechanisms of the antitumor effects of supplemental oxygenation
- (2015) Stephen M. Hatfield et al. Science Translational Medicine
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment
- (2015) Claire Vanpouille-Box et al. VACCINE
- Intratumoral Myeloid Cells Regulate Responsiveness and Resistance to Antiangiogenic Therapy
- (2015) Lee B. Rivera et al. Cell Reports
- Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
- (2015) T. Kouo et al. Cancer Immunology Research
- Radiotherapy Combined with the Immunocytokine L19-IL2 Provides Long-lasting Antitumor Effects
- (2015) C. M. L. Zegers et al. CLINICAL CANCER RESEARCH
- Pressing the right buttons: signaling in lymphangiogenesis
- (2014) S. Coso et al. BLOOD
- Tumor Vessel Normalization by Chloroquine Independent of Autophagy
- (2014) Hannelore Maes et al. CANCER CELL
- Angiogenesis revisited – role and therapeutic potential of targeting endothelial metabolism
- (2014) Peter Stapor et al. JOURNAL OF CELL SCIENCE
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Oxidative Stress Regulates Expression of VEGFR1 in Myeloid Cells: Link to Tumor-Induced Immune Suppression in Renal Cell Carcinoma
- (2014) S. Kusmartsev et al. JOURNAL OF IMMUNOLOGY
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- The Value of Tumor Infiltrating Lymphocytes (TILs) for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
- (2014) Yan Mao et al. PLoS One
- MicroRNAs and Tumor Vasculature Normalization: Impact on Anti-Tumor Immune Response
- (2013) Agata Matejuk et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
- (2013) Andrea Casazza et al. CANCER CELL
- Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
- (2013) Katrien De Bock et al. CELL
- Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
- (2013) Jonathan Welti et al. JOURNAL OF CLINICAL INVESTIGATION
- Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
- (2013) Rikke B. Holmgaard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Combining two strategies to improve perfusion and drug delivery in solid tumors
- (2013) T. Stylianopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma
- (2013) Laura M. Alwan et al. Targeted Oncology
- The New Era of the Lymphatic System: No Longer Secondary to the Blood Vascular System
- (2013) I. Choi et al. Cold Spring Harbor Perspectives in Medicine
- Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs
- (2012) Jason G. Cyster et al. Annual Review of Immunology
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Inhibiting Systemic Autophagy during Interleukin 2 Immunotherapy Promotes Long-term Tumor Regression
- (2012) X. Liang et al. CANCER RESEARCH
- Targeting TNF- to Neoangiogenic Vessels Enhances Lymphocyte Infiltration in Tumors and Increases the Therapeutic Potential of Immunotherapy
- (2012) A. Calcinotto et al. JOURNAL OF IMMUNOLOGY
- Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
- (2012) Vikash P. Chauhan et al. Nature Nanotechnology
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
- (2012) Y. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- VEGF-C Promotes Immune Tolerance in B16 Melanomas and Cross-Presentation of Tumor Antigen by Lymph Node Lymphatics
- (2012) Amanda W. Lund et al. Cell Reports
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma
- (2011) T. K. Eigentler et al. CLINICAL CANCER RESEARCH
- Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
- (2011) Barbara Molon et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Common Lymphatic Endothelial and Vascular Endothelial Receptor-1 Mediates the Transmigration of Regulatory T Cells across Human Hepatic Sinusoidal Endothelium
- (2011) Shishir Shetty et al. JOURNAL OF IMMUNOLOGY
- Regulation of Immune Responses by Prostaglandin E2
- (2011) P. Kalinski JOURNAL OF IMMUNOLOGY
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
- (2011) Andrea Facciabene et al. NATURE
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- Interaction of tumor cells and lymphatic vessels in cancer progression
- (2011) A Alitalo et al. ONCOGENE
- TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth
- (2011) T J Standiford et al. ONCOGENE
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- Impaired lymphatic contraction associated with immunosuppression
- (2011) S. Liao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
- (2010) R. K. Shrimali et al. CANCER RESEARCH
- Lymphangiogenesis: Molecular Mechanisms and Future Promise
- (2010) Tuomas Tammela et al. CELL
- Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
- (2010) Anna I. Markowska et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- The VEGF IRESes are differentially susceptible to translation inhibition by miR-16
- (2009) Z. S. Karaa et al. RNA
- The angiogenic switch in carcinogenesis
- (2009) Vanessa Baeriswyl et al. SEMINARS IN CANCER BIOLOGY
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
- (2008) Li Yang et al. CANCER CELL
- The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
- (2008) Takuya Osada et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3
- (2008) Pasquale Fasanaro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Macrophage activation and polarization
- (2007) Fernando Oneissi Martinez Frontiers in Bioscience-Landmark
- Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
- (2007) Ronald J Buckanovich et al. NATURE MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started